Biosimilars: Transforming Patient Care in Oncology and Immunology
By Dara Shahrokh Ph.D., Medical Advisor, Pharmaceuticals The introduction of biosimilars has represented a significant leap forward in the global
Read moreBy Dara Shahrokh Ph.D., Medical Advisor, Pharmaceuticals The introduction of biosimilars has represented a significant leap forward in the global
Read moreBy Aik Choon Tan, Ph.D. Senior Director of Data Science, Jon M. and Karen Huntsman Endowed Chair in Cancer Data
Read more